Fortune November 7, 2019
A “genomic revolution” in healthcare has been declared for years, but now, says Simone Song, founding partner at healthcare-focused venture capital fund ORI Capital, it’s really arrived.
Genomic sequencing—the ordering of DNA bases within a genome to decode genetic information—has become indispensable in research across biotechnology, forensic biology, and medical diagnosis. But analyzing the information it produces takes time.
Now, however, a handful of biotech startups are training A.I. to analyze huge amounts of genomic data at a much faster rate than humans would be able to carry out.
That step forward—to A.I.-powered genomic sequencing—is “almost a dream” for uses like early cancer detection, Song told the Fortune Global Tech Forum in Guangzhou, China on Thursday....
Today's Sponsors
Today's Sponsor